News Archive

University of Maryland University College recently swept two divisions of the Maryland Cyber Challenge for the second consecutive year, capturing first place in the College and Professional divisions of the premier Maryland cyber competition held at the annual Cyber Maryland conference in Baltimore.

“This is a tough competition and to beat many great teams just to get to the finals in the college and professional divisions is an amazing accomplishment. We fielded four teams for this competition (two in each division) and all four made it to the final round. That speaks to the quality of our teams, ” said Jeff Tjiputra, chairman of UMUC’s undergraduate cybersecurity program and academic advisor to the cyber competition teams. 

The Pentagon’s technology arm is prepared to invest up to $700,000 in a promising idea in the field of biological sciences and technology. The goal is to turn theoretical concepts into actual products, such as better sensors for prosthetic limbs and techniques to cope with infectious disease outbreaks.

Under a new initiative by the Defense Advanced Research Projects Agency, inventors will be able to send in proposals without having to trudge through miles of red tape as they would have to in traditional government contracts.

Photo Credit: DARPA

Dr. William Kirwan, chancellor for the University System of Maryland, announced over the summer that he will be stepping down, but not until his replacement is hired.

He’s lost count of the number of college graduations he’s been a part of since taking the job as Maryland’s education chancellor more than a decade ago.

The Tax Foundation’s State Business Tax Climate Index enables business leaders, government policymakers, and taxpayers to gauge how their states’ tax systems compare. While there are many ways to show how much is collected in taxes by state governments, the Index is designed to show how well states structure their tax systems, and provides a road-map to improving these structures.

Johns Hopkins University, Biomedical Engineering, CBIDMonday, December 8, 2014 from 3:00 PM to 7:30 PM (EST)Baltimore, MD

Join us December 8th for a review of 16 exciting healthcare design projects at the Johns Hopkins Center for Bioengineering Innovation & Design (CBID).  CBID MSE and Undergraduate projects will be presented.  This year we’re honored to have as our Keynote Speaker Dr. John Kostuik.  Dr. Kostuik is Co-Founder and Chief Medical Officer of K2M Inc, a world leading spine surgery company.  The event will also have a Shark Tank competition with a panel of tough judges and real cash prizes.  Refreshments will be provided.

Considering that Emergent BioSolutions (NYSE: EBS  ) has regular government contracts and other manufacturing contracts — so regular that it’s willing to give quarterly guidance, which many companies wouldn’t dream of — it was a little surprising to see by how much the biotech beat the guidance it gave three months earlier. Third-quarter revenue came in at $138 million, substantially higher than the guidance of $110 million to $125 million it gave three months ago.

But, as it turns out, this is just an accounting issue. In the third quarter, Emergent BioSolutions set up a collaboration with MorphoSys to develop its prostate cancer drug candidate ES414. Under the terms of the agreement, Emergent BioSolutions got a $20 million upfront payment — the biotech recognized $15.3 million of this in the third quarter. Back out the payment, and Emergent BioSolutions’ revenue falls within its previous guidance, fortunately at the upper-end.

The National Institute of Standards and Technology and the University of Maryland have collaborated to build a new center that will preform studies on how to store, process and transmit data using quantum architecture.

The Joint Center for Quantum Information and Computer Science is designed to complement basic quantum research being done at an institute run by NIST, UMD and the National Security Agency, NIST said Oct. 31.

Inspired by a series of new strategic initiatives, BioNJ announced a rebranding today — BioNJ, The Gateway to Health – that reflects an expanded vision and mission directed to fostering a vibrant life sciences ecosystem in New Jersey where science is supported, companies are created, drugs are developed and patients are paramount.

The rebranding is supported by the launch of a revitalized website at www.BioNJ.org that is contemporary in its look and represents the determination of BioNJ to help move the life sciences industry forward.

The National Institutes of Health is challenging science innovators to compete for prizes totaling up to $500,000, by developing new ways to track the health status of a single cell in complex tissue over time. The NIH Follow that Cell Challenge seeks tools that would, for example, monitor a cell in the process of becoming cancerous, detect changes due to a disease-causing virus, or track how a cell responds to treatment.

The challenge aims to generate creative ideas and methods for following and predicting a single cell’s behavior and function over time in a complex multicellular environment – preferably using multiple integrated measures to detect its changing state.

Cartagenia announced today that it and Qiagen’s bioinformatics business are part of a consortium that has received €1.4 million ($1.7 million) in funding from a European funding initiative to support the development of software tools for personalized genetic analysis of cancer variants.

The Lungcadia program will combine the technologies and expertise of Cartagenia, Qiagen, and the Institute of Pathology at Hannover Medical School and will focus on lung cancer as a disease model, but the partners aim to make the results applicable to other types of cancer. The project has received the funding from the EuroTransBio initiative, which supports biotech collaborations in Europe.